" class="no-js "lang="en-US"> Respiratory Archives - Medtech Alert
Sunday, March 03, 2024

Sort by:

Date

Top Post

Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations

Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to […]

Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a […]

Tri-anim Health Services Announces Exclusive Relationship to Distribute Brainscope's Breakthrough Technology for Mild Head Injury Including Concussion, Into Emergency Departments

Tri-anim Health Services, a specialty distributor of respiratory, anesthesia and critical care products and therapies, […]

£10.4m Full-service Contract Signed With Existing Big Pharma Client

Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world […]

Naobios Delivers Flugen Inc’s M2SR Influenza Vaccine Candidate for Upcoming Clinical Trials

Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of […]

Vironix Health has Partnered with The Landon Pediatric Foundation to Bring AI-Healthcare Technology to Southern California

Digital Health Company Vironix Health has teamed up with LPF to increase access to affordable healthcare and […]

Pfizer Completes Acquisition of ReViral

Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of ReViral, a privately […]

BenevolentAI Achieves Third Milestone in Its AI-enabled Drug Discovery Collaboration With AstraZeneca

BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI-enabled drug discovery company, today announces that AstraZeneca […]

Hundreds of Patients to Get Life-extending Lung Cancer Drug on the NHS

Hundreds of people with a form of the most common form of lung cancer could […]

Optellum Attains CE Marking for Its Early Lung Cancer Diagnosis AI Technology

Optellum, an Oxford-based medtech company that provides breakthrough AI technologies to help with early diagnosis of […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more